NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Participants can register here for the virtual event airing 9:00am ET /…
QUALITY HORTICULTURE ANNOUNCES PREMIUM BRAND PORTFOLIO EXPANSION INTO USA
ONTARIO, Calif., Dec. 17, 2024 /PRNewswire/ -- Quality Horticulture Ltd. ("Quality"), a…
Xiamen empowers autistic youth to realize their value
XIAMEN, China, Dec. 17, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn-…
Harris Dental Unveils Cutting-Edge Technologies to Revolutionize Patient Care
CAPE COD, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- When it comes…
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
Reviva Announces Proposed Public Offering
December 16, 2024 17:18 ET | Source: Reviva Pharmaceuticals CUPERTINO, Calif., Dec.…
Apu Apustaja and Mental Health America Forge Ground-breaking Partnership to Champion Mental Well-Being in Web3
Washington, DC, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emerging blockchain pioneer Apu…
Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posts Strong Adjusted EBITDA Margin1 for Fiscal Year 2024 and Returns to…
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg
– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C…
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
Tech transfer of MVA-BN® will help increase global mpox vaccine manufacturing capacity…
